Prosecution Insights
Last updated: May 28, 2026
Application No. 18/730,317

PIGMENT AND METHOD FOR PRODUCING SAME, SOLUTION, METAL HYDROXYL AMOUNT EVALUATION METHOD, AND METAL HYDROXYL PROCESSING RATE EVALUATION METHOD

Final Rejection §103§112
Filed
Jul 19, 2024
Priority
Feb 24, 2022 — JP 2022-026890 +1 more
Examiner
AHVAZI, BIJAN
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Kyoto University
OA Round
2 (Final)
64%
Grant Probability
Moderate
3-4
OA Rounds
10m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allowance Rate
762 granted / 1200 resolved
-1.5% vs TC avg
Strong +47% interview lift
Without
With
+46.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
64 currently pending
Career history
1279
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
84.6%
+44.6% vs TC avg
§102
9.3%
-30.7% vs TC avg
§112
3.3%
-36.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1200 resolved cases

Office Action

§103 §112
DETAILED ACTION 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2. This Office Action is responsive to the amendment filed on 02/26/2026. 3. Claims 1-17 are pending. Claims 1-17are under examination on the merits. Claims 1-2, 4-5 are amended. 4. The objections and rejections not addressed below are deemed withdrawn. 5. Applicant’s arguments with respect to claims 1-17 have been considered but are moot because the arguments do not apply to any of the references being used in the current rejection. Information Disclosure Statement 6. The information disclosure statements submitted on 02/26/2026, and 03/05/2026 are in compliance with the provisions of 37 CFR 1.97. Accordingly, the examiner has considered the information disclosure statements. Claim Rejections - 35 USC § 112 7. The following is a quotation of the fourth paragraph of 35 U.S.C. 112: Subject to the [fifth paragraph of 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. 8. Claims 2-3 are rejected under 35 USC 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of a previous claim. Applicant is required to cancel the claim, or amend the claim to place the claim in proper dependent form, or rewrite the claim in independent form. Claim 2, as written, depends on claim 1, which recites “Y1 is selected from hydrogen, a halogen group, a methyl group, an alkoxy group, a phenyl group, a diphenylamide group, a thiophenyl group, or a phenylethynyl group”, however, based on the content of the claim 1,Y1 is Br moiety. Thus, claim 2 as being of improper dependent form for failing to further limit the subject matter of a previous claim 1. Claim 3 being depended on claim 2 is rejected as well. 9. Claim 4 is rejected under 35 USC 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of a previous claim. Applicant is required to cancel the claim, or amend the claim to place the claim in proper dependent form, or rewrite the claim in independent form. Claim 4, as written, depends on claim 1, which recites “Y1 is selected from hydrogen, a halogen group, a methyl group, an alkoxy group, a phenyl group, a diphenylamide group, a thiophenyl group, or a phenylethynyl group”, however, based on the content of the claim 1,Y1 is Br moiety. Thus, claim 4 as being of improper dependent form for failing to further limit the subject matter of a previous Claim Rejections - 35 USC § 103 10. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. 11. Claims 1-5 are rejected under 35 U.S.C. 103(a)(1) as being unpatentable over Gon et al. (Vapochromic Luminescent π-Conjugated Systems with Reversible Coordination-Number Control of Hypervalent Tin(IV)-Fused Azobenzene Complexes, Chem. Eur. J. 2021, 27, 7561-7571, hereinafter “Gon”). Regarding claims 1-4: Gon teaches a pigment, wherein the pigment is the syntheses of the tin(IV)-fused azobenzene (TAz) complexes with halogens (TAz-F). (Page 7562, left Col., Results and Discussion, Scheme 1). Gon does not expressly teach Y1 is Br. PNG media_image1.png 172 406 media_image1.png Greyscale However, the subject matter as a whole would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention was made, since it is held to be a prima facie case of obviousness since a person of ordinary skill in the art would have recognized the interchangeability of the element (i.e. functional group) shown in the prior art for the corresponding element disclosed in the specification wherein the side chains syntheses merely done by routine experimentation. Regarding claim 5: Gon teaches a solution comprising: a pigment, wherein the pigment is the syntheses of the tin(IV)-fused azobenzene (TAz) complexes with halogens (TAz-F) (Page 7562, left Col., Results and Discussion, Scheme 1), and an organic solvent, wherein a concentration of the pigment is 1 x 10⁻10 mol/L or more and 1 mol/L or less (Page 7564, Fig. 2). PNG media_image1.png 172 406 media_image1.png Greyscale PNG media_image2.png 372 398 media_image2.png Greyscale Allowable Subject Matter 12. Claims 6-17 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Gon is considered to be the closest prior art. Gon teaches a solution comprising: a pigment, wherein the pigment is the syntheses of the tin(IV)-fused azobenzene (TAz) complexes with halogens (TAz-F) (Page 7562, left Col., Results and Discussion, Scheme 1), and an organic solvent, wherein a concentration of the pigment is 1 x 10⁻10 mol/L or more and 1 mol/L or less (Page 7564, Fig. 2). Gon does not expressly teach a metal hydroxyl amount evaluation method as set forth. Therefore, the instant claims are distinguished over the prior art. Response to Arguments 13. Applicant’s arguments with respect to claims 1-17 have been considered but are moot because the arguments do not apply to any of the references being used in the current rejection. 14. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Examiner Information 15. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Bijan Ahvazi, Ph.D. whose telephone number is (571) 270-3449. The examiner can normally be reached on Mon-Fri 9.00 A.M. -7 P.M.. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on 571-272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Bijan Ahvazi/ Primary Examiner, Art Unit 1763 03/10/2026 bijan.ahvazi@uspto.gov
Read full office action

Prosecution Timeline

Jul 19, 2024
Application Filed
Nov 21, 2025
Non-Final Rejection mailed — §103, §112
Feb 12, 2026
Response Filed
Mar 12, 2026
Final Rejection mailed — §103, §112
May 20, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637604
SILICON-CONTAINING THERMALLY CONDUCTIVE PASTES
2y 10m to grant Granted May 26, 2026
Patent 12637612
FLUORESCENT OPIOID BINDING COMPOUND AND USES THEREOF
2y 9m to grant Granted May 26, 2026
Patent 12637421
ANTHRAQUINONE COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING SAID COMPOUND, AND DIMMING ELEMENT
1y 7m to grant Granted May 26, 2026
Patent 12630725
COLOR ENHANCEMENT UTILIZING UP CONVERTERS AND/OR DOWN CONVERTERS
2y 6m to grant Granted May 19, 2026
Patent 12618003
Electrochromic Devices and Compositions Including Poly((diallyldimethylammonium Bis (Substituted-Sulfonyl)Imide Anion))
3y 0m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
64%
Grant Probability
99%
With Interview (+46.7%)
2y 9m (~10m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1200 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month